Skip to main content
logo
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
65.34
-0.58 (-0.87%)
At close: Feb 11, 2026, 4:00 PM EST
65.39
+0.06 (0.08%)
After-hours: Feb 11, 2026, 4:10 PM EST

Tarsus Pharmaceuticals Revenue

Tarsus Pharmaceuticals had revenue of $118.70M in the quarter ending September 30, 2025, with 146.68% growth. This brings the company's revenue in the last twelve months to $366.10M, up 182.44% year-over-year. In the year 2024, Tarsus Pharmaceuticals had annual revenue of $182.95M with 948.62% growth.

Revenue (ttm)
$366.10M
Revenue Growth
+182.44%
P/S Ratio
7.28
Revenue / Employee
$1,133,437
Employees
323
Market Cap
2.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024182.95M165.51M948.62%
Dec 31, 202317.45M-8.37M-32.42%
Dec 31, 202225.82M-31.21M-54.73%
Dec 31, 202157.03M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.02B
Catalyst Pharmaceuticals578.20M
Travere Therapeutics435.83M
Arcus Biosciences240.00M
IDEAYA Biosciences214.83M
Viridian Therapeutics70.79M
Beam Therapeutics55.70M
Immunome9.68M
Revenue Rankings

TARS News

More News